| |
n = 2584
|
n = 1748
|
n = 6397
|
|
Age (years)
|
62 (± 6)
|
64 (± 6)
|
64 (± 6)
|
|
Male gender (%)
|
38%
|
66%
|
64%
|
|
BMI (kg/m
2
)
|
35.9 (± 4.8)
|
33.4 (± 4.1)
|
34.0 (± 4.4)
|
|
Weight (kg)
|
97.4 (± 16.1)
|
95.0 (± 14.8)
|
95.8 (± 15.4)
|
|
Waist circumference, men (cm)
|
117 (± 12)
|
112 (± 10)
|
114 (± 10)
|
|
Waist circumference, women (cm)
|
111 (± 12)
|
104 (± 11)
|
109 (± 11)
|
|
Systolic blood pressure (mmHg)
|
141 (± 12)
|
136 (± 13)
|
138 (± 13)
|
|
Diastolic blood pressure (mmHg)
|
78 (± 8)
|
78 (± 8)
|
77 (± 9)
|
|
Pulse (bpm)
|
75 (± 10)
|
68 (± 10)
|
71 (± 10)
|
|
Creatinine clearance (mL/min/1.73 m
2
)
|
76 [48;105]
|
72 [47;99]
|
71 [41;103]
|
|
Uric acid concentration (μmol/L)
|
342 (± 87)
|
369 (± 86)
|
374 (± 98)
|
|
Glucose concentration (mmol/L)
|
9.0 (± 3.1)
|
6.0 (± 1.0)
|
8.9 (± 3.2)
|
|
HDL cholesterol (mmol/L)
|
1.3 (± 0.3)
|
1.2 (± 0.3)
|
1.2 (± 0.3)
|
|
LDL cholesterol (mmol/L)
|
3.1 (± 0.9)
|
3.0 (± 0.9)
|
3.0 (± 1.0)
|
|
Triglycerides (mmol/L)
|
2.2 (± 1.5)
|
2.0 (± 1.1)
|
2.4 (± 1.4)
|
|
History of dyslipidaemia (%)
|
71%
|
76%
|
86%
|
|
History of stroke (%)
|
0%
|
9%
|
12%
|
|
Peripherial artery disease (%)
|
0%
|
8%
|
16%
|
|
Use of alcohol (%)
|
51%
|
63%
|
54%
|
|
Current smokers (%)
|
11%
|
10%
|
9%
|
|
Coronary artery disease (%)
|
4%
|
87%
|
83%
|
|
CHF (%)
|
2%
|
9%
|
11%
|
|
Use of diuretics (%)
|
45%
|
37%
|
51%
|
|
Use of Insulin (%)
|
26%
|
0.5%
|
32%
|
|
Use of statins (%)
|
42%
|
73%
|
73%
|
|
Use of ACE-inhibitors (%)
|
73%
|
64%
|
82%
|
|
Use of Ca
2+
-blockers (%)
|
32%
|
33%
|
40%
|
|
Use of fibrates (%)
|
10%
|
6%
|
10%
|
|
Urinary dip stick for glucose:
| | | |
|
Negative (%)
|
81%
|
99%
|
79%
|
|
Trace (%)
|
6%
|
0.4%
|
6%
|
|
1+ (%)
|
4%
|
0.2%
|
5%
|
|
2+ (%)
|
3%
|
0.1%
|
3%
|
|
3+ (%)
|
6%
|
0.4%
|
6%
|
